insights_auto
Why is CLBT down 5.10%?
Dive Deeperchevron_right
CLBT:NASDAQ
Cellebrite DI Ltd
$10.79
arrow_downward
-5.10%(-0.58) 1D
$10.81
arrow_upward
+0.19% (+0.020)bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CLBT...
Open
$11.34
High
$11.34
Low
$10.70
Mkt. cap
2.71B
Avg. vol.
4.51M
Volume
3.43M
P/E ratio
46.51
52-wk high
$19.98
52-wk low
$9.58
EPS
$0.23
Beta
1.15
Shares outstanding
251.34M
No. of employees
1K
Open
$11.34
High
$11.34
Low
$10.70
Mkt. cap
2.71B
Avg. vol.
4.51M
Volume
3.43M
P/E ratio
46.51
52-wk high
$19.98
52-wk low
$9.58
EPS
$0.23
Beta
1.15
Shares outstanding
251.34M
No. of employees
1K
News stories
From web sources and news partners
Stock Titan
·
2 hours ago
Cellebrite (CLBT) CEO Ramji Shiven’s share award begins vesting in May 2027
MarketBeat
·
16 hours ago
Cellebrite DI Ltd. (NASDAQ:CLBT) Stock Rated "Moderate Buy" by Sell-Side Analysts
Profile
Cellebrite DI Ltd. is an Israeli digital forensics company headquartered in Petah Tikva that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.
Cellebrite's largest shareholder is Sun Corporation, which is based in Nagoya, Japan. Cellebrite has fourteen offices around the world including business centers in Washington, D.C., Munich, and in Singapore. In 2021, the Cellebrite company was valued at approximately $2.4 billion. Wikipedia
About Cellebrite DI Ltd